October 28,2016 Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood
April 02,2015 FORTRESS BIOTECH (f/k/a Coronado Biosciences) FORMS NEW SUBSIDIARY, HELOCYTE, INC. (f/k/a DiaVax Biosciences) TO DEVELOP NOVEL IMMUNOTHERAPIES FOR CYTOMEGALOVIRUS
